A recent study has shown vascular calcification associated with increased risk of mortality in CKD rats after FGF23 neutralization by chronic treatment with a FGF23 antibody [35], suggesting the importance of maintaining physiological levels of circulating FGF23. This evidence concerns the gene FGF23 and chronic kidney disease.